952-841-2345
 

Call Us Today: 952-841-2345

Call Us Today: 952-841-2345

Imagine your life
with less pain

Visit the
pain management
experts at Twin Cities
Pain Clinic and let us
help you get back the
life you deserve.

Call Us Today: 952-841-2345

March 1, 2023 eclipsedev

People with Painful Diabetic Neuropathy Can Now Receive the Only Spinal Cord Stimulator FDA-Approved for the Condition at Twin Cities Pain Clinic

Painful diabetic neuropathy causes pain in the limbs that is often managed by medicine that is inadequate for long-term relief.

Edina, Minn., November 1, 2021 – Twin Cities Pain Clinic is now proudly offering spinal cord stimulation (SCS) therapy for the treatment of painful diabetic neuropathy (PDN). The technology is a newly approved nondrug treatment for PDN and is the only SCS system with a specific indication to treat the condition.

More than 34 million people in the U.S. have diabetes, and it’s estimated that 20-25% of people with diabetes will develop PDN.  The condition is associated with a wide range of symptoms including pain in the limbs described as burning, freezing, stabbing, shooting, hypersensitivity or deep aching. Traditional treatment options for PDN include over-the-counter medications, prescription medications, physical therapy and injections, but for many people, these options are inadequate for long-term relief.

HFX for PDN is the only spinal cord stimulation system approved by the Food and Drug Administration (FDA) with a specific indication for PDN. HFX is a comprehensive solution that includes a Senza spinal cord stimulation system and support services for the treatment of chronic pain. HFX for PDN means that a patient has been implanted with a Senza System and programmed to include a frequency of 10 kHz.

The Senza device is implanted during a quick and minimally invasive procedure, and then begins delivering mild pulses at a high frequency directly to the spinal cord to stop pain signals from reaching the brain. In a recent study, 92% of patients reported high satisfaction with the therapy.

“People with PDN know it to be a cruel addition to the chronic disease they must fight every day,” said Dr. Andrew J. Will, founder and medical director of Twin Cities Pain Clinic. “HFX for PDN offers a new option to alleviate this agonizing and persistent sensation. There is no other therapy like this, and I believe it can make a real difference for our patients suffering from PDN.”

Twin Cities Pain Clinic is one of the foremost authorities on neurostimulation therapy in the country, performing hundreds of procedures every year and partaking in extensive research studies to advance stimulation technology. On numerous occasions, they have been hand-picked my medical device companies to be the first pain group in the state of Minnesota to perform their latest pain treatments.

Twin Cities Pain Clinic was recently recognized as the best pain clinic in the state, as voted by the residents of Minnesota in the Star Tribune’s 2021 Minnesota’s Best awards. Their associated ambulatory surgery center in Edina, Twin Cities Surgery Center, also took top honors in the contest, being voted the best surgery center in the state.

For important safety information regarding the new HFX treatment, please visit www.HFXforPDN.com.

About Twin Cities Pain Clinic

Twin Cities Pain Clinic is a comprehensive pain management organization that has been helping patients achieve relief from chronic pain since 2003. As a leading authority in the field of chronic pain management, our organization is committed to providing every patient with a customized treatment plan consisting of the most advanced and effective therapies to provide optimal outcomes. To learn more or schedule an appointment, go online to www.twincitiespainclinic.com or call (952) 841-2345.

 

MEDIA CONTACT

Jeffrey Blanchard

Marketing Manager

Jeffrey.blanchard@tcpain.com

(952) 204-3556

CDC 2020 National Diabetes Statistics

Schmader KE et al. Clin J Pain. 2002;18(6):350-354

Peltier A, et al. BMJ. 2014;348g1799.

Petersen EA, et al. JAMA Neurol. Published online April 05, 2021. doi:10.1001/jamaneurol.2021.0538

COVID-19 UPDATE >>
Telemedicine and in-clinic appointments available. Schedule today: 952-841-2345